Digital Polymerase Chain Reaction (dPCR) is an advancement of traditional polymerase chain reaction (PCR). The traditional PCR with its limited precision and accuracy often fail to amplify small samples of nucleic acid to a detectable level. This has evoked a need of better techniques to assess the minute quantities of DNA or RNA. dPCR is more sensitive and reliable technique with improved ability to quantify the absolute amount of nucleic acid. It divides the sample into large number of fragments, each containing either one or no template nucleic acid sequence. After DNA amplification, scoring is done with the help of fluorescence, counting the score as positive for the fraction containing template sequence and negative for the sample without the template sequence. The major factors driving the global digital polymerase chain reaction market are increasing demand for innovative diagnostic techniques, increasing disease awareness, need for early diagnosis of viral, infectious and genetic disease, and increasing number of diagnostic centers across the globe. However, high cost of dPCR testing and limited expertise and accessibility, especially in the developing countries are likely to restrict the market growth.
The global digital polymerase chain reaction (dPCR) market is segmented on the basis of technology, type, application, end user and geography. According to technology, the market is segmented into Droplet Digital PCR (ddPCR) and BEAMing Digital PCR. On the basis of type, the market is segmented into Digital PCR equipment and consumables. Based on application, it is segmented into clinical diagnostics, research and others. On the basis of end user, the market is segmented into pharmaceuticals and biotechnology industries, hospitals and clinical diagnostic centers, and university and research organizations. Geographically, the market is segmented across four regions viz., North America, Europe, Asia-Pacific, and LAMEA.
New product launch is among the few strategies adopted by key industry players. Recently, JN Medsys, in collaboration with Institute of Bioengineering and Nanotechnology (IBN) introduced Clarity Digital PCR system for the detection of mutations in cancer and fetal abnormalities. It is a technologically advanced product, provided with reduced preparation time and simplified workflow. The companies profiled in this report include Thermo Fisher Scientific Inc., RainDance Technologies Inc., Bio-Rad Laboratories Inc., Fluidigm Corporation, Formulatrix Inc., Promega Corporation, JN Medsys Pte Ltd. and Stilla Technologies.
KEY MARKET BENEFITS
Comprehensive analysis of factors that drive and restrict the growth of the global digital polymerase chain reaction (dPCR) market is provided
The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
An in-depth analysis of key segments of the market demonstrate the types of dPCR equipment along with the technologies, applications and end-users in the dPCR market
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
Region-wise digital polymerase chain reaction market conditions are comprehensively analyzed in the report
KEY MARKET SEGMENTS:
The global Digital Polymerase Chain Reaction (dPCR) market is segmented below:
Global Digital Polymerase Chain Reaction (dPCR) Market - By Technology
Droplet Digital PCR (ddPCR)
BEAMing Digital PCR
Global Digital Polymerase Chain Reaction (dPCR) Market - By Type
Digital PCR equipment
Consumables and reagents
Global Digital Polymerase Chain Reaction (dPCR) Market - By Application
Global Digital Polymerase Chain Reaction (dPCR) Market - By End User
Pharmaceuticals and biotechnology industries
Hospitals and clinical diagnostic centers
University and research organizations
Global Digital Polymerase Chain Reaction (dPCR) Market - By Geography